TITLE

The efficacy of voriconazole in the treatment of 192 fungal central nervous system infections: a retrospective analysis

AUTHOR(S)
Schwartz, S.; Reisman, A.; Troke, P. F.
PUB. DATE
June 2011
SOURCE
Infection;Jun2011, Vol. 39 Issue 3, p201
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Purpose: The efficacy of voriconazole against fungal central nervous system (CNS) infections was examined retrospectively. Methods: Voriconazole-treated patients with proven (137) or probable (55) CNS infections were identified in the voriconazole database (114) and the literature (78). Investigator-determined success was a complete or partial response. Survival was calculated from the start of voriconazole therapy. Results: The patients' age range was <1-81 years (median 43) and 127 (66%) were male. Aspergillus spp. (63%) and Scedosporium spp. (18%) predominated, but 12 other genera were recorded. Underlying conditions were haematopoietic stem cell transplantation (HSCT, 35), haematologic malignancy (HM, 35), solid-organ transplantation (SOT, 25), chronic immunosuppression (CI, 40) and other conditions (OC, 57). The median voriconazole therapy duration was 93 days (range 1-1,128), with success in 93 patients (48%). Only 35 patients received primary therapy, with success in 63% versus 45% for salvage ( p = 0.06 NS). Underlying conditions influenced success; HSCT 14%, HM 54%, SOT 40%, CI 45% and OC 72% ( p < 0.001). Additional antifungal combination therapy (37 patients) gave a trend towards an improved response rate ( p = 0.09) and superior survival ( p = 0.0149), while patients receiving neurosurgical interventions (72) showed superior responses ( p = 0.0174) and survival ( p = 0.0399). In all, 49% of patients died, 71% (67/94) due to fungal infection. The overall median survival was 297 days (range 3 to >2,000). Paediatric ( p = 0.014) and literature patients ( p < 0.001) exhibited superior survival compared with adults and voriconazole database patients, respectively. Conclusions: Voriconazole shows encouraging efficacy against various CNS fungal infections. Combination therapy and/or CNS surgery may improve outcomes.
ACCESSION #
62519541

 

Related Articles

  • Outcome Analysis of Invasive Aspergillosis in Hematologic Malignancy and Hematopoietic Stem Cell Transplant Patients: The Role of Novel Antimold Azoles. RAMOS, ELIZABETH R.; JIANG, YING; HACHEM, RAY; KASSIS, CHRISTELLE; KONTOYIANNIS, DIMITRIOS P.; RAAD, ISSAM // Oncologist;Jul2011, Vol. 16 Issue 7, p1049 

    Background. Invasive aspergillosis (IA) continues to be a leading cause of morbidity and mortality in hematologic malignancy (HM) patients.We evaluated the prognostic factors for IA in HM patients. Methods. In this retrospective study, we included all HM patients diagnosed with proven or...

  • Incidence and Factors Influencing Oral Mucositis in Patients with Hematopoietic Stem Cell Transplantation. Kwan Suk Jo; Nam Cho Kim // Journal of Korean Academy of Nursing;2014, Vol. 44 Issue 5, p542 

    Purpose: This study was done to examine the incidence of oral mucositis in hematopoietic stem cell transplantation patients and to identify factors influencing oral mucositis and patient outcomes according to severity. Methods: In this retrospective study, data were collected from electronic...

  • Mortality after bloodstream infections in allogeneic haematopoietic stem cell transplant (HSCT) recipients. Mikulska, M.; Del Bono, V.; Bruzzi, P.; Raiola, A.; Gualandi, F.; Lint, M.; Bacigalupo, A.; Viscoli, C. // Infection;Jun2012, Vol. 40 Issue 3, p271 

    Purpose: Bloodstream infections (BSIs) are frequent after allogeneic haematopoietic stem cell transplantation (HSCT). The aim of this study was to identify predictors of mortality after BSI in patients who undergo HSCT. Methods: Patients who underwent HSCT between 1 January 2004 and 31 January...

  • Prognostic Importance of Pretransplant Functional Capacity After Allogeneic Hematopoietic Cell Transplantation. Jones, Lee W.; Devlin, Sean M.; Maloy, Molly A.; Wood, William A.; Tuohy, Sharlynn; Espiritu, Noel; Aquino, Jennifer; Kendig, Tiffany; Michalski, Meghan G.; Gyurkocza, Boglarka; Schaffer, Wendy L.; Ali, Benzar; Giralt, Sergio; Jakubowski, Ann A. // Oncologist;Nov2015, Vol. 20 Issue 11, p1290 

    Background. The purpose of this study was to investigate the prognostic importance of functional capacity in patients undergoing allogeneic hematopoietic cell transplantation (HCT) for hematological malignancies. Patients and Methods. Using a retrospective design, 407 patients completed a...

  • Adherence to osteoporosis medications amongst Singaporean patients. Cheen, M.; Kong, M.; Zhang, R.; Tee, F.; Chandran, M. // Osteoporosis International;Mar2012, Vol. 23 Issue 3, p1053 

    Summary: Compliance and persistence to bisphosphonates amongst Singaporean patients with osteoporosis were estimated. Mean medication possession ratio (MPR) ± standard deviation (SD) was 78.9 ± 27.5%, and 69.0% was persistent at 1 year. In contrast to US and Europe where poor adherence is...

  • Does Obesity Influence the Prognosis of Metastatic Renal Cell Carcinoma in Patients Treated with Vascular Endothelial Growth Factor-Targeted Therapy? STEFFENS, SANDRA; GRÜNWALD, VIKTOR; RINGE, KRISTINA I.; SEIDEL, CHRISTOPH; EGGERS, HENDRIK; SCHRADER, MARK; WACKER, FRANK; KUCZYK, MARKUS A.; SCHRADER, ANDRES J. // Oncologist;Nov2011, Vol. 16 Issue 11, p1565 

    Background. Obesity increases the risk for renal cell carcinoma (RCC). However, it has only recently been identified as an independent positive prognostic factor for localized RCC. Objective. To determine whether obesity influences long-term prognosis in metastatic RCC patients receiving...

  • Impact of Molecular Alterations and Targeted Therapy in Appendiceal Adenocarcinomas. Raghav, Kanwal P.S.; Shetty, Aditya V.; Kazmi, Syed M.A.; Zhang, Nianxiang; Morris, Jeffrey; Taggart, Melissa; Fournier, Keith; Royal, Richard; Mansfield, Paul; Eng, Cathy; Wolff, Robert A.; Overman, Michael J. // Oncologist;Dec2013, Vol. 18 Issue 12, preceding p1271 

    Background. Appendiceal adenocarcinomas (AAs) are rare and this has limited their molecular understanding. The purpose of our study was to characterize the molecular profile of AA and explore the role of targeted therapy against cyclooxygenase- 2 (COX-2) and epidermal growth factor receptor...

  • The Role of Secondary Cytoreductive Surgery in Patients with Recurrent Epithelial Ovarian, Tubal, and Peritoneal Cancers: A Comparative Effectiveness Analysis. CHI-MU CHUANG; YIING-JENG CHOU; MING-SHYEN YEN; KUAN-CHONG CHAO; NAE-FANG TWU; HUA-HSI WU; KUO-CHANG WEN; YI-JEN CHEN; PENG-HUI WANG; CHUNG-RU LAI; PESUS CHOU // Oncologist;Jun2012, Vol. 17 Issue 6, p847 

    Background. All published reports concerning secondary cytoreductive surgery for relapsed ovarian cancer have essentially been observational studies. However, the validity of observational studies is usually threatened from confounding by indication. We sought to address this issue by using...

  • Gonadotropin-Releasing Hormone Agonist Cotreatment During Chemotherapy May Increase Pregnancy Rate in Survivors. Blumenfeld, Zeev; Zur, Hilli; Dann, Eldad J. // Oncologist;Nov2015, Vol. 20 Issue 11, p1283 

    Background. The use of gonadotropin-releasing hormone analogs (GnRHas) for fertility preservation is not unequivocally accepted. It is controversial whether GnRHa can increase the pregnancy rate in survivors. Patients and Methods. This is a retrospective cohort study. Every patient referred for...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics